Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

Cited by (982)

Items 601–700 of 982

1. Convening on the influenza human viral challenge model for universal influenza vaccines, Part 2: Methodologic considerations
   Bruce L. Innis, Francesco Berlanda Scorza, Jeremy S. Blum, Varsha K. Jain, Anastazia M. Older Aguilar, Diane J. Post, Paul C. Roberts, Niteen S. Wairagkar, Janet White, Joseph Bresee · 2019 · Vaccine
2. Vaccination of aged mice with adjuvanted recombinant influenza nucleoprotein enhances protective immunity
   Tres S. Cookenham, Kathleen G. Lanzer, Emily Gage, Erica C. Lorenzo, Darrick Carter, Rhea N. Coler, Susan L. Baldwin, Laura Haynes, William W. Reiley, Marcia A. Blackman · 2020 · Vaccine
3. Systems Immunology: Revealing Influenza Immunological Imprint
   Adriana Tomić, Andrew John Pollard, Mark M. Davis · 2021 · Viruses
4. Human SARS-CoV-2 challenge resolves local and systemic response dynamics
   Rik G.H. Lindeboom, Kaylee B. Worlock, Lisa M. Dratva, Masahiro Yoshida, David Scobie, Helen R. Wagstaffe, Laura Richardson, Anna Wilbrey-Clark, Josephine L. Barnes, Krzysztof Polański et al. · 2023 · medRxiv
5. Influenza Virus in Community-Acquired Pneumonia: Current Understanding and Knowledge Gaps
   Jiuyang Xu, Jiapei Yu, Luning Yang, Fei Zhou, Hui Li, Bin Cao · 2020 · Seminars in Respiratory and Critical Care Medicine
6. Granzyme B: A Double-Edged Sword in the Response to Influenza Infection in Vaccinated Older Adults
   Chris P. Verschoor, Graham Pawelec, Laura Haynes, Mark B Loeb, Melissa Kathryn Andrew, George A. Kuchel, Janet E. McElhaney · 2021 · Frontiers in Aging
7. Neutrophil-to-lymphocyte ratio as a potential biomarker in predicting influenza susceptibility
   Guoyun Wang, Cheng Lv, Cheng Liu, Wenjun Shen · 2022 · Frontiers in Microbiology
8. Therapeutic mitigation of measles-like immune amnesia and exacerbated disease after prior respiratory virus infections in ferrets
   Robert M. Cox, Josef D. Wolf, Nicole A. P. Lieberman, Carolin M. Lieber, Hae‐Ji Kang, Zachary M. Sticher, Jeong-Joong Yoon, Meghan K. Andrews, Mugunthan Govindarajan, Rebecca E. Krueger et al. · 2024 · Nature Communications
9. Cytotoxic CD4+ T Cells Are Induced during Infection with Chlamydia trachomatis
   Joanna Olivas, Caterina Nogueira, Jennifer D. Helble, Michael N. Starnbach · 2024 · The Journal of Immunology
10. Pediatric influenza vaccination: understanding the T-cell response
    Rogier Bodewes, Pieter LA Fraaij, Albert D. M. E. Osterhaus, Guus F. Rimmelzwaan · 2012 · Expert Review of Vaccines
11. Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities?
    Babak Jalilian, Stig Hill Christiansen, Halldór Bjarki Einarsson, Mehdi R Pirozyan, Eskild Petersen, Thomas Vorup‐Jensen · 2013 · Molecular and Cellular Therapies
12. Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells
    Freek Cox, Matthijs Baart, Jeroen Huizingh, Jeroen T. B. M. Tolboom, Liesbeth Dekking, Jaap Goudsmit, Eiríkur Saeland, Katarina Radošević · 2015 · PLoS ONE
13. Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model
    Daniel J. Fullen, Nicolas Noulin, Andrew P. Catchpole, Hosnieh Fathi, Edward J. Murray, Alex Mann, Kingsley Eze, Ganesh Balaratnam, Daryl W. Borley, Anthony Gilbert et al. · 2016 · PLoS ONE
14. Pulmonary changes in Norwegian fatal cases of pandemic influenza H1N1 (2009) infection: a morphologic and molecular genetic study
    Pål Voltersvik, Lara A. Aqrawi, Susanne Gjeruldsen Dudman, Olav Hungnes, Norwegian Lung Pathology Group, Leif Henry Bostad, Karl Albert Brokstad, Rebecca Jane Cox · 2016 · Influenza and Other Respiratory Viruses
15. Cathepsin L Helps to Defend Mice from Infection with Influenza A
    Xiang Ming Xu, John R. Greenland, Jeffrey E. Gotts, Michael A. Matthay, George H. Caughey · 2016 · PLoS ONE
16. A single cycle influenza virus coated in H7 haemagglutinin generates neutralizing antibody responses to haemagglutinin and neuraminidase glycoproteins and protection from heterotypic challenge
    Timothy J. Powell, Pramila Rijal, Rosanna M. McEwen-Smith, Haewon Byun, Marc Hardwick, Lisa M. Schimanski, Kuan-Ying Arthur Huang, Rodney Stuart Daniels, Alain Townsend · 2019 · Journal of General Virology
17. Influenza–Host Interplay and Strategies for Universal Vaccine Development
    Hye Suk Hwang, Mincheol Chang, Yoong Ahm Kim · 2020 · Vaccines
18. An Antigenic Thrift-Based Approach to Influenza Vaccine Design
    Jai S. Bolton, Hannah Klim, Judith Wellens, Matthew D. Edmans, Uri Obolski, Craig Thompson · 2021 · Vaccines
19. Seroresponse to Inactivated and Recombinant Influenza Vaccines Among Maintenance Hemodialysis Patients
    Harold J. Manley, Eduardo K. Lacson Jr., Gideon N. Aweh, Nien Chen Li, Daniel E. Weiner, Dana C. Miskulin, Caroline M. Hsu, Toros Kapoian, Mary S. Hayney, Klemens B. Meyer et al. · 2022 · American Journal of Kidney Diseases
20. Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections
    Mohamed I. M. Ahmed, Paulina Diepers, Christian Janke, Michael Plank, Tabea M. Eser, Raquel Rubio‐Acero, Anna Fuchs, Olga Baranov, Noemi Castelletti, Inge Kroidl et al. · 2022 · Frontiers in Immunology
21. Respiratory virus-induced heterologous immunity
    Emanuel Pusch, Harald E. Renz, Chrysanthi L. Skevaki · 2018 · Allergo Journal
22. Reduction of influenza virus transmission from mice immunized against conserved viral antigens is influenced by route of immunization and choice of vaccine antigen
    Graeme E. Price, Chia-Yun Lo, Julia A. Misplon, Suzanne L. Epstein · 2018 · Vaccine
23. Cell-Mediated Immune Responses After Influenza Vaccination of Solid Organ Transplant Recipients: Secondary Outcomes Analyses of a Randomized Controlled Trial
    Arnaud Grégoire L’Huillier, Victor H. Ferreira, Cédric Hirzel, Yoichiro Natori, Jaclyn Slomovic, Terrance Ku, Katja Höschler, Matthew Ierullo, Nazia Selzner, Jeffrey R. Schiff et al. · 2019 · The Journal of Infectious Diseases
24. Dominant CD 4‐dependent RNA‐dependent RNA polymerase‐specific T‐cell responses in children acutely infected with human enterovirus 71 and healthy adult controls
    Shuangsuo Dang, Ning Gao, Yaping Li, Mei Li, Xiufang Wang, Xiaoli Jia, Song Zhai, Xin Zhang, Jingkun Liu, Huiling Deng et al. · 2013 · Immunology
25. Preexisting CD4+ T-Cell Immunity in Human Population to Avian Influenza H7N9 Virus: Whole Proteome-Wide Immunoinformatics Analyses
    Venkata R. S. K. Duvvuri, Bhargavi Duvvuri, Christilda Alice, Gillian E. Wu, Jonathan B. Gubbay, Jianhong Wu · 2014 · PLoS ONE
26. Lung cell fates during influenza
    Brianna Jarboe, Maria Shubina, Ryan Andrew Langlois, David F. Boyd, Siddharth Balachandran · 2025 · Cell Research
27. Multiantigen pan-sarbecovirus DNA vaccines generate protective T cell immune responses
    Jeroen van Bergen, Marcel G M Camps, Iris N. Pardieck, Dominique M. B. Veerkamp, Wing Yan Leung, Anouk A. Leijs, Sebenzile K. Myeni, Marjolein Kikkert, Ramon Arens, Gerben C. M. Zondag et al. · 2023 · JCI Insight
28. Correlative CD4 and CD8 T-cell immunodominance in humans and mice: Implications for preclinical testing
    Tertuliano Alves Pereira Neto, John Sidney, Alba Grifoni, Alessandro Sette · 2023 · Cellular and Molecular Immunology
29. Cobra Hemagglutinin and cGAMP Loaded Ace‐Dex Microparticles Provide a Broadly Active and Shelf‐Stable Influenza Vaccine Platform
    Dylan A. Hendy, Erik S. Pena, Cole J. Batty, Luis Alberto Ontiveros-Padilla, John A. Roque, Timothy A. Dixon, Denzel D. Middleton, Michael A. Carlock, Ted M. Ross, Eric M. Bachelder et al. · 2023 · Advanced Therapeutics
30. Immunogenicity of an adjuvanted broadly active influenza vaccine in immunocompromised and diverse populations
    Dylan A. Hendy, Erik S. Pena, Luis Alberto Ontiveros-Padilla, Timothy A. Dixon, Denzel D. Middleton, Grace L. Williamson, Nicole Rose Lukesh, Sean R. Simpson, Rebeca T. Stiepel, Jahirul Islam et al. · 2023 · Bioengineering & Translational Medicine
31. Cellular Interferon Gamma and Granzyme B Responses to Cytomegalovirus-pp65 and Influenza N1 Are Positively Associated in Elderly
    Heidi Theeten, Catharina Matheï, Kelly Peeters, Benson Ogunjimi, Herman Goossens, Margareta M. Ieven, Pierre Van Damme, Nathalie Cools · 2016 · Viral Immunology
32. DNA Methylation Patterns in CD4+ T Cells of Naïve and Influenza A Virus-Infected Mice Developmentally Exposed to an Aryl Hydrocarbon Receptor Ligand
    Catherine G. Burke, Jason R. Myers, Christina M. Post, Lisbeth A. Boulé, B. Paige Lawrence · 2021 · Environmental Health Perspectives
33. SARS CoV-2 infections in healthcare workers with a pre-existing T-cell response: a prospective cohort study
    José L. Casado, Johannes Häemmerle, Pilar Vizcarra, Héctor Velasco, Tamara Velasco, Marina Fernández-Escribano, Alejandro Vallejo · 2021 · Clinical Microbiology and Infection
34. Fusion Protein of Rotavirus VP6 and SARS-CoV-2 Receptor Binding Domain Induces T Cell Responses
    Kirsi Tamminen, Suvi Heinimäki, Stina Gröhn, Vesna Blazevic · 2021 · Vaccines
35. Can T Cells Abort SARS-CoV-2 and Other Viral Infections?
    Leo Swadling, Mala K. Maini · 2023 · International Journal of Molecular Sciences
36. T cell control of SARS-CoV-2: When, which, and where?
    Mariana O. Diniz, Mala K. Maini, Leo Swadling · 2023 · Seminars in Immunology
37. Helping Themselves: Optimal Virus-Specific CD4 T Cell Responses Require Help via CD4 T Cell Licensing of Dendritic Cells
    Matthew Richard Olson, Shirley G. K. Seah, Jolie G. Cullen, Marie Greyer, Kathryn M. Edenborough, Peter C. Doherty, Sammy Bedoui, Andrew M. Lew, Stephen J Turner · 2014 · The Journal of Immunology
38. Aflunov®: a vaccine tailored for pre-pandemic and pandemic approaches against influenza
    Giuseppe Del Giudice, Elena Fragapane, Giovanni Della Cioppa, Rino Rappuoli · 2012 · Expert Opinion on Biological Therapy
39. Meta-Analysis and Potential Role of Preexisting Heterosubtypic Cellular Immunity Based on Variations in Disease Severity Outcomes for Influenza Live Viral Challenges in Humans
    Olga Pleguezuelos, Stuart Robinson, Ana Fernandez, Gregory A. Stoloff, Wilson Caparrós‐Wanderley · 2015 · Clinical and Vaccine Immunology
40. Evaluating Influenza Vaccines: Progress and Perspectives
    Elena Gianchecchi, Claudia Maria Trombetta, Simona Piccirella, Emanuele Montomoli · 2016 · Future Virology
41. Behavioral strategies to prevent and mitigate COVID-19 infection
    Noah T. Hutchinson, Andrew J. Steelman, Jeffrey A. Woods · 2020 · Sports Medicine and Health Science
42. Differences in Influenza-Specific CD4 T-Cell Mediated Immunity Following Acute Infection Versus Inactivated Vaccination in Children
    Ian Shannon, Chantelle L. White, Hongmei Yang, Jennifer Lynn Nayak · 2020 · The Journal of Infectious Diseases
43. Is a Human CD8 T-Cell Vaccine Possible, and if So, What Would It Take?
    Andrew James McMichael · 2017 · Cold Spring Harbor Perspectives in Biology
44. Effect of mucosal adjuvant IL-1β on heterotypic immunity in a pig influenza model
    Anna P. Schmidt, Basudev Paudyal, Sonia Villanueva-Hernández, Adam McNee, Eleni Vatzia, Brigid Veronica Carr, Selma Schmidt, Amy Mccarron, Veronica Martini, Silke Schroedel et al. · 2023 · Frontiers in Immunology
45. Memory CD4+ T cells: beyond “helper” functions
    Kobporn Boonnak, Kanta Subbarao · 2012 · Journal of Clinical Investigation
46. Prior Population Immunity Reduces the Expected Impact of CTL-Inducing Vaccines for Pandemic Influenza Control
    Kirsty J. Bolton, James M. McCaw, Lorena E. Brown, David Charles Jackson, Katherine Kedzierska, Jodie McVernon · 2015 · PLoS ONE
47. Whole-Inactivated Influenza Virus Is a Potent Adjuvant for Influenza Peptides Containing CD8+ T Cell Epitopes
    Peter Christiaan Soema, Sietske K. Rosendahl Huber, Geert-Jan Willems, Ronald H. J. Jacobi, Marion Hendriks, Ernst C. Soethout, Wim Jiskoot, Jørgen de Jonge, Josine van Beek, Gideon F. A. Kersten et al. · 2018 · Frontiers in Immunology
48. Influenza vaccines: ‘tailor-made’ or ‘one fits all’
    Giulietta Saletti, Thomas H. Gerlach, Guus F. Rimmelzwaan · 2018 · Current Opinion in Immunology
49. Mouse Models Reveal Role of T-Cytotoxic and T-Reg Cells in Immune Response to Influenza: Implications for Vaccine Design
    Stewart Sell, Karl Kai McKinstry, Tara M. Strutt · 2019 · Viruses
50. An Orf-Virus (ORFV)-Based Vector Expressing a Consensus H1 Hemagglutinin Provides Protection against Diverse Swine Influenza Viruses
    Gabriela Mansano do Nascimento, Dina Bugybayeva, Veerupaxagouda Patil, Jennifer Schrock, Ganesh Yadagiri, Gourapura J. Renukaradhya, Diego G. Diel · 2023 · Viruses
51. Single-Dose CpG Immunization Protects Against a Heterosubtypic Challenge and Generates Antigen-Specific Memory T Cells
    Alexander J. Vogel, Deborah M. Brown · 2015 · Frontiers in Immunology
52. Role of the host genetic variability in the influenza A virus susceptibility.
    Ana Carolina Arcanjo, Giovanni Mazzocco, Silviene Fabiana de Oliveira, Dariusz Plewczyński, Jan P. Radomski · 2014 · Acta Biochimica Polonica
53. Seasonal coronaviruses and SARS-CoV-2: effects of preexisting immunity during the COVID-19 pandemic
    Gang Wang, Ze Xiang, Wei Wang, Zhi Chen · 2022 · Journal of Zhejiang University SCIENCE B
54. High-Dimensional Analysis of Human CD8+ T Cell Phenotype, Function, and Antigen Specificity
    Evan William Newell, Wenyu Lin · 2013 · Current topics in microbiology and immunology
55. Effects of thermal water inhalation in chronic upper respiratory tract infections in elderly and young patients
    Thea Magrone, Mauro Galantino, Nunzio Di Bitonto, Luisella Borraccino, Gerardo Chiaromonte, Emilio Jirillo · 2016 · Immunity & Ageing
56. Immunogenicity and protective efficacy of an intranasal neuraminidase-based influenza vaccine with bacterial cell membrane-derived adjuvants
    Kirill Vasilyev, Irene Hoxie, Eduard Puente‐Massaguer, Joshua Yueh, Disha Bhavsar, Maya Singh, Corey P. Mallett, Joseph Zimmermann, Florian Krammer · 2025 · npj Vaccines
57. Understanding immunity to influenza: implications for future vaccine development
    Ralph A. Tripp · 2023 · Expert Review of Vaccines
58. Meeting Report From “Correlates of Protection for Next Generation Influenza Vaccines: Lessons Learned From the COVID‐19 Pandemic”
    Florian Krammer, Jacqueline M. Katz, Othmar G. Engelhardt, Diane J. Post, Paul C. Roberts, Sheena G. Sullivan, Stephen Mark Tompkins, Christopher Chiu, Stacey Schultz‐Cherry, Rebecca Jane Cox · 2024 · Influenza and Other Respiratory Viruses
59. Adjuvant-free, self−assembling ferritin nanoparticle vaccine coupled with influenza virus hemagglutinin protein carrying M1 and PADRE epitopes elicits cross-protective immune responses
    Yongqiang Zhao, Shuangshuang Guo, Jia Liu, Yating Wang, Bo Wang, Chun Peng, Enqi Du · 2025 · Frontiers in Immunology
60. Alveolar Macrophages in Influenza A Infection Guarding the Castle with Sleeping Dragons
    Lindsay Somerville, Amber N. Cardani, Thomas J. Braciale · 2020
61. Triphasic production of IFN γ by innate and adaptive lymphocytes following influenza A virus infection
    George E. Finney, Kerrie E Hargrave, Marieke Pingen, Thomas Purnell, David Todd, Freya MacDonald, Julie C. Worrell, Megan K. L. MacLeod · 2023 · Discovery Immunology
62. Preclinical evaluation of Vaxfectin®-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines
    Larry R Smith, Walter Wodal, Brian A. Crowe, Astrid Kerschbaum, Peter Bruehl, Michael G. Schwendinger, Helga Savidis-Dacho, Seán M. Sullivan, Mark Shlapobersky, Jukka Hartikka et al. · 2013 · Human Vaccines & Immunotherapeutics
63. The influence of changing host immunity on 1918–19 pandemic dynamics
    Kirsty J. Bolton, James M. McCaw, Jodie McVernon, John D. Mathews · 2014 · Epidemics
64. Refining the Approach to Vaccines Against Influenza a Viruses with Pandemic Potential
    Rita Czakó, Kanta Subbarao · 2015 · Future Virology
65. A heat-inactivated H7N3 vaccine induces cross-reactive cellular immunity in HLA-A2.1 transgenic mice
    Giuseppina Di Mario, Bruno Garulli, Ester Sciaraffia, Marzia Facchini, Isabella Donatelli, Maria Rita Castrucci · 2016 · Virology Journal
66. Topical CpG Oligodeoxynucleotide Adjuvant Enhances the Adaptive Immune Response against Influenza A Infections
    Wing Ki Cheng, Adam W. Plumb, Jacqueline C.Y. Lai, N. B. Abraham, Jan Peter Dutz · 2016 · Frontiers in Immunology
67. Identification of a First Human Norovirus CD8+ T Cell Epitope Restricted to HLA-A*0201 Allele
    Maria Malm, Timo Vesikari, Vesna Blazevic · 2018 · Frontiers in Immunology
68. Memory CD4+ T cells enhance B‐cell responses to drifting influenza immunization
    Emily Gage, Neal Van Hoeven, Natasha Dubois Cauwelaert, Sasha E. Larsen, Jesse H. Erasmus, Mark T. Orr, Rhea N. Coler · 2018 · European Journal of Immunology
69. Cross‐reactive antibody‐dependent cellular cytotoxicity antibodies are increased by recent infection in a household study of influenza transmission
    Sophie A. Valkenburg, Vicky J. Fang, Nancy Leung, Daniel K. W. Chu, Dkm Ip, Ranawaka A. P. M. Perera, Yizhuo Wang, Athena PY Li, Malik J. S. Peiris, Benjamin John Cowling et al. · 2019 · Clinical & Translational Immunology
70. The COVID-19 Vaccine Landscape
    Till Koch, Anahita Fathi, Marylyn M. Addo · 2021 · Advances in experimental medicine and biology
71. The Immune Response to Respiratory Viruses: From Start to Memory
    Tom D. Y. Reijnders, Alex R. Schuurman, Tom van der Poll · 2021 · Seminars in Respiratory and Critical Care Medicine
72. B Cells and Functional Antibody Responses to Combat Influenza
    Giuseppe Lofano, Arun Kumar, Oretta Finco, Giuseppe Del Giudice, Sylvie Bertholet · 2015 · Frontiers in Immunology
73. Effect of memory CD4+ T cells’ signal transducer and activator of transcription (STATs) functional shift on cytokine-releasing properties in asthma
    Zhihong Chen, Jue Pan, Yi Jia, Dandan Li, Zhihui Min, Xiaoqiong Su, Honglei Yuan, Geng Shen, Shengxuan Cao, Lei Zhu et al. · 2016 · Cell Biology and Toxicology
74. The challenges of a neglected STI: Molluscum contagiosum.
    Leonardo Zichichi, Mario Maniscalco · 2012 · PubMed
75. T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response
    Leonard Moise, Bethany Girard, Christine Boyle, Neşe Kurt Yılmaz, Hyesun Jang, Celia A. Schiffer, Ted M. Ross, William D Martin, Anne Searls De Groot · 2018 · Human Vaccines & Immunotherapeutics
76. Mucosal boosting increases protective efficacy of an influenza vaccine in mice
    Liping Wang, Chi Ngai Chan, Jayeshbhai Chaudhari, David L. Hope, Alejandro A. Espinosa Perez, Ninaad Lasrado, Zhenyu Li, Alejandra Waller-Pulido, Dalia N. Cabrera-Barragan, Brookelynne Verrette et al. · 2025 · iScience
77. Lung structural cells are altered by influenza virus leading to rapid immune protection following re-challenge
    Julie C. Worrell, Kerrie E Hargrave, George E. Finney, Chris A. H. Hansell, John J Cole, Jagtar Singh Nijjar, Fraser R. Morton, Marieke Pingen, Tom Purnell, Kathleen A. J. Mitchelson et al. · 2025 · Nature Communications
78. Older Adults Who Maintained a Regular Physical Exercise Routine before the Pandemic Show Better Immune Response to Vaccination for COVID-19
    Brenda Rodrigues Silva, Fernanda Rodrigues Monteiro, Kizzy Cezário, Jônatas Bussador do Amaral, Vitória Paixão, Ewin Barbosa Almeida, Carlos A. F. Santos, Gislene Rocha Amirato, Danielle Bruna Leal Oliveira, Edison Luíz Durigon et al. · 2023 · International Journal of Environmental Research and Public Health
79. COVID-19 patients display changes in lymphocyte subsets with a higher frequency of dysfunctional CD8lo T cells associated with disease severity
    L. Onofrio, Constanza Marín, J. Dutto, María Belén Brugo, R. E. Baigorrí, Sabrina N. Bossio, J. N. Quiróz, L. Almada, Federico N. Ruiz Moreno, Carolina Olivera et al. · 2023 · Frontiers in Immunology
80. Cellular and Molecular Immunity to Influenza Viruses and Vaccines
    Jane Kasten‐Jolly, David A. Lawrence · 2024 · Vaccines
81. Orally dissolving film as a potential vaccine delivery carrier to prevent influenza virus infection
    Keon-Woong Yoon, Ki‐Back Chu, Gi-Deok Eom, Jie Mao, Sung-Soo Kim, Fu‐Shi Quan · 2024 · Antiviral Research
82. Targeting of nucleoprotein to chemokine receptors by DNA vaccination results in increased CD8+-mediated cross protection against influenza
    Marta Baranowska, Anna Germundsson Hauge, Chloé Hoornaert, Bjarne Bogen, Gunnveig Grødeland · 2015 · Vaccine
83. Cell-Mediated Immunity Against Antigenically Drifted Influenza A(H3N2) Viruses in Children During a Vaccine Mismatch Season
    Jin Hyang Kim, Margarita Mishina, Jessie R. Chung, Kelly Stefano Cole, Mary Patricia Nowalk, Judith M. Martin, Sarah Spencer, Brendan L. Flannery, Richard Kent Zimmerman, Suryaprakash R. Sambhara · 2016 · The Journal of Infectious Diseases
84. Plasmacytoid Dendritic Cells Contribute to the Protective Immunity Induced by Intranasal Treatment with Fc-fused Interleukin-7 against Lethal Influenza Virus Infection
    Moon Cheol Kang, Han Wook Park, Donghoon Choi, Young Woo Choi, Yunji Park, Young Chul Sung, Seung‐Woo Lee · 2017 · Immune Network
85. The manufacturing of human viral challenge agents for use in clinical studies to accelerate the drug development process
    Andrew P. Catchpole, Daniel J. Fullen, Nicolas Noulin, Alex Mann, Anthony S. Gilbert, Rob Lambkin‐Williams · 2018 · BMC Research Notes
86. Legacy of the influenza pandemic 1918: The host T cell response
    Andrew James McMichael · 2018 · Biomedical Journal
87. Pregnancy-related immune suppression leads to altered influenza vaccine recall responses
    Nishel Mohan Shah, Nesrina Imami, Peter Kelleher, William Barclay, Mark Richard Johnson · 2019 · Clinical Immunology
88. Experimental PCEP-Adjuvanted Swine Influenza H1N1 Vaccine Induced Strong Immune Responses but Did Not Protect Piglets against Heterologous H3N2 Virus Challenge
    Royford Bundi Magiri, Ken Lai, George Mutwiri, Heather L. Wilson · 2020 · Vaccines
89. Severity of heterosubtypic influenza virus infection in ferrets is reduced by live attenuated influenza vaccine
    Anthony C. Marriott, Karen E. Gooch, Phillip J. Brown, Kathryn A. Ryan, Nicola J. Jones, Natasha Merredew, Nathan R. Wiblin, Oliver Dibben, Helen Bright, Bassam Hallis et al. · 2021 · npj Vaccines
90. Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults
    Chris P. Verschoor, Laura Haynes, Graham Pawelec, Mark B Loeb, Melissa Kathryn Andrew, George A. Kuchel, Janet E. McElhaney · 2021 · Frontiers in Aging
91. A diagnostic model for serious COVID-19 infection among older adults in Shanghai during the Omicron wave
    Suxia Bao, Guanzhu Lu, Yaoyue Kang, Yuanyuan Zhou, Yuhuan Wang, Lei Yan, Donglin Yin, Yu-Jie Bao, Xiaoling Yuan, Jie Xu · 2022 · Frontiers in Medicine
92. Suppression by Thimerosal of Ex-Vivo CD4+ T Cell Response to Influenza Vaccine and Induction of Apoptosis in Primary Memory T Cells
    Emily Loison, Béatrice Poirier-Beaudouin, Valérie Seffer, Audrey Paoletti, Véred Abitbol, Éric Tartour, Odile Launay, Marie‐Lise Gougeon · 2014 · PLoS ONE
93. Vaccines in the Prevention of Viral Pneumonia
    Clementine S. Fraser, Akhilesh Jha, Peter Openshaw · 2016 · Clinics in Chest Medicine
94. Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine
    Yoshikazu Honda‐Okubo, Harinda Rajapaksha, Dimitar Sajkov, David Gordon, Manon M. J. Cox, Nikolai Petrovsky · 2017 · Human Vaccines & Immunotherapeutics
95. Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza
    Andrew C Hayward, L. WANG, Nilu P Goonetilleke, Ellen Fragaszy, A Bermingham, Adina N. MacMahon Copas, Oliver Dukes, Erc Millett, Irwin Nazareth, JS Nguyen-Van-Tarn et al. · 2015 · UCL Discovery (University College London)
96. Advancing Treatment Options for Influenza: Challenges With the Human Influenza Challenge
    Alicia M. Fry, Weimin Zhong, Larisa V. Gubareva · 2014 · The Journal of Infectious Diseases
97. Vaccination with Deglycosylated Modified Hemagglutinin Broadly Protects against Influenza Virus Infection in Mice and Ferrets
    Limin Zhang, Junyu Chen, Chenguang Shen, Guosong Wang, Zhen Zhong Lu, Dian Zeng, Ying Gao, Huiqing Chen, Ningshao Xia, Yixin Chen · 2022 · Vaccines
98. A bovine adenoviral-vector-based universal influenza vaccine confers protection against influenza A and B viruses in mice and ferrets
    Wen-Chien Wang, Ekramy E. Sayedahmed, Marwa Alhashimi, Ahmed Elkashif, Vivek Gairola, Muralimanohara S. T. Murala, S. Sambhara, Suresh K. Mittal · 2025 · Molecular Therapy: Nucleic Acids
99. The role of T cells in influenza infection and vaccination
    Yuxuan Li, Chenxi Zhu, Wang Yi, Heather E. Miller, Kamel Benlagha, Maria G. Byazrova, Alexander V. Filatov, Lu Yang, Chaohong Liu · 2026 · Virologica Sinica
100. Respiratory viral infections: knowledge based therapeutics
     Tracy Hussell, Alexandra Godlee, Samira Salek‐Ardakani, Robert J. Snelgrove · 2012 · Current Opinion in Immunology